Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRAT domain containing 1 (LRATD1) is a protein-coding gene that encodes a protein containing a LRAT (lecithin retinol acyltransferase) domain, but it is distinct from enzymes such as LRAT itself. It is involved in the regulation of cell morphogenesis and cell motility and is predicted to localize to the cytoplasm[3][5][7][8]. The gene may have a role in developmental disorders such as Feingold syndrome 1, but it is not classified as a classical therapeutic target like an enzyme, receptor, transporter, or ion channel[3]. No drugs are currently known to interact with it, and its precise molecular mechanism and functions remain poorly understood. Notes: - LRAT domain containing 1 should not be confused with lecithin retinol acyltransferase (LRAT), which is an enzyme involved in vitamin A metabolism[2]. - There are no known clinical drugs or inhibitors targeting LRATD1, and it is not recognized as a standard pharmacological, enzymatic, or receptor target in biomedical research[3][5][7]. - No major safety or therapeutic concerns are reported, reflecting limited clinical or functional characterization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRAT domain containing 1 (LRATD1).